PMAIP1 regulates autophagy in osteoblasts via the AMPK/mTOR pathway in osteoporosis
Human Cell · 2024
DOI: 10.1007/s13577-024-01067-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Cell, 2024. Verfasst von Yijie Gao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation Medicine, The Second Hospital of Dalian Medical University, Dalian, Liaoning, People's Republic of China. Hauptthemen laut MEDLINE: AMP-Activated Protein Kinases, Autophagy, Disease Models, Animal, Osteoblasts. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: the Second Hospital of Dalian Medical University.
Abstract (Originalsprache)
Osteoporosis (OP) is a highly prevalent disorder characterized by low bone mass that severely reduces patient quality of life. Although numerous treatments for OP have been introduced in clinic, many have side effects and high costs. Therefore, there is still an unmet need for optimal solutions. Here, raw signal analysis was used to identify potential high-risk factors for OP, and the biological functions and possible mechanisms of action (MOAs) of these factors were explored via gene set enrichment analysis (GSEA). Subsequently, molecular biological experiments were performed to verify and analyze the discovered risk factors in vitro and in vivo. PMAIP1 was identified as a potential risk factor for OP and significantly suppressed autophagy in osteoblasts via the AMPK/mTOR pathway, thereby inhibiting the proliferation and differentiation of osteoblasts. Furthermore, we constructed an ovariectomy (OVX) model of OP in rats and simultaneously applied si-PMAIP1 for in vivo interference. si-PMAIP1 upregulated the expression of LC3B and p-AMPK and downregulated the expression of p-mTOR, and these effects were reversed by the autophagy inhibitor. Micro-CT revealed that, si-PMAIP1 significantly inhibited the development of osteoporosis in OVX model rats, and this therapeutic effect was attenuated by treatment with an autophagy inhibitor. This study explored the role and mechanism of PMAIP1 in OP and demonstrated that PMAIP1 may serve as a novel target for OP treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rehabilitation Medicine, The Second Hospital of Dalian Medical University, Dalian, Liaoning, People's Republic of China.
- Dalian Medical University, Dalian, Liaoning, People's Republic of China.
- Department of Joint Surgery, Dalian Municipal Central Hospital, Dalian, Liaoning, People's Republic of China.
- Department of Joint Surgery, Dalian Municipal Central Hospital, Dalian, Liaoning, People's Republic of China. zyt890928@163.com.
- Department of Rehabilitation Medicine, The Second Hospital of Dalian Medical University, Dalian, Liaoning, People's Republic of China. dyx90116@163.com.
Förderung
- the Second Hospital of Dalian Medical University
Zitieren
APA
Gao, Y., Huang, A., Zhao, Y., & Du, Y. (2024). PMAIP1 regulates autophagy in osteoblasts via the AMPK/mTOR pathway in osteoporosis. Human Cell. https://doi.org/10.1007/s13577-024-01067-w
Vancouver
Gao Y, Huang A, Zhao Y, Du Y. PMAIP1 regulates autophagy in osteoblasts via the AMPK/mTOR pathway in osteoporosis. Human Cell. 2024. doi:10.1007/s13577-024-01067-w
BibTeX
@article{Gao2024,
author = {Gao, Yijie and Huang, Anquan and Zhao, Yantao and Du, Yunxia},
title = {PMAIP1 regulates autophagy in osteoblasts via the AMPK/mTOR pathway in osteoporosis},
journal = {Human Cell},
year = {2024},
doi = {10.1007/s13577-024-01067-w}
}
EUVIMED